RT @Docrhumato: Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis…
Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy | Orphanet Journal of Rare Diseases | Full Text https://t.co/kvY4gscUCO
Study of Val30Met ATTR #amyloidosis-related neuropathy demonstrates that neurologic disease progression strongly depends on baseline neurologic severity: https://t.co/ogkcLKzdMY. https://t.co/Eu9jFTGtub
RT @GrupoOrpharSEFH: Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafam…
RT @GrupoOrpharSEFH: Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafam…
RT @amyloid_papers: Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafami…
Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy. https://t.co/iitNsRGeVL
RT @GrupoOrpharSEFH: Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafam…
Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy https://t.co/zgkhBtmopy